← Eichor
Study identifier: NCT06404931 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

Condition: Prolapse; Female · Prolapse Genital · Prolapse Uterovaginal  ·  Sponsor: Hospital Mutua de Terrassa

PhasePhase 2
Planned participants90
Who can joinFemale, 18 Years to 100 Years
Healthy volunteersNo

About this study

This is a randomised study in which we compare the effectiveness of three different procedures in mending symptomatic anterior and apical prolapse in patients who are candidates to receive surgery. They will be randomly assigned in a ratio 1:1:1 to three different groups who will have assigned three different kinds of surgery. In the patients of the first group a classic vaginal hysterectomy with anterior colporrhaphy will be practised. Patients who belong to group two will undergo a vaginal hysterectomy followed by placement of an acellular dermal matrix from cadaveric donors (hADM) for anterior reinforcement and sacrospinous fixation with Anchorsure® device (Neomedic trade mark (TM) International, Spain). Finally, patients from group three will have vaginal hysterectomy followed by sacrospinous fixation with Anchorsure® alone . Patients will be followed-up at 4 weeks, 6 months, 12 months and annually till 36 months to evaluate relapses and possible complications.

This description comes directly from the study's public registry record.

Talk to the study team

Gerard Molina  ·  +34937365050

Pilar Arcusa  ·  +34937365050

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Mutua de TerrassaTerrassa, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06404931